Ireland - English - HPRA (Health Products Regulatory Authority)

cipla (eu) limited - montelukast sodium - film coated tablet - 10 milligram - leukotriene receptor antagonists - leukotriene receptor antagonist - it is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting
-agonists provide inadequate clinical control of asthma. in those asthmatic patients in whom montelukast is indicated in asthma, montelukast can also provide symptomatic relief of seasonal allergic rhinitis.